ASPIRA PATHLAB & DIAGNOSTICS | RAINBOW CHILDRENS MEDICARE | ASPIRA PATHLAB & DIAGNOSTICS / RAINBOW CHILDRENS MEDICARE |
|||
---|---|---|---|---|---|
P/E (TTM) | x | -12.6 | 62.2 | - | View Chart |
P/BV | x | 2.4 | 13.0 | 18.5% | View Chart |
Dividend Yield | % | 0.0 | 0.2 | - |
ASPIRA PATHLAB & DIAGNOSTICS RAINBOW CHILDRENS MEDICARE |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
ASPIRA PATHLAB & DIAGNOSTICS Mar-23 |
RAINBOW CHILDRENS MEDICARE Mar-23 |
ASPIRA PATHLAB & DIAGNOSTICS / RAINBOW CHILDRENS MEDICARE |
5-Yr Chart Click to enlarge
|
||
High | Rs | 75 | 885 | 8.5% | |
Low | Rs | 26 | 410 | 6.3% | |
Sales per share (Unadj.) | Rs | 14.0 | 115.6 | 12.2% | |
Earnings per share (Unadj.) | Rs | -0.1 | 20.9 | -0.4% | |
Cash flow per share (Unadj.) | Rs | 1.5 | 29.8 | 4.9% | |
Dividends per share (Unadj.) | Rs | 0 | 3.00 | 0.0% | |
Avg Dividend yield | % | 0 | 0.5 | 0.0% | |
Book value per share (Unadj.) | Rs | 12.4 | 104.4 | 11.9% | |
Shares outstanding (eoy) | m | 10.29 | 101.50 | 10.1% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 3.6 | 5.6 | 64.0% | |
Avg P/E ratio | x | -583.7 | 30.9 | -1,886.2% | |
P/CF ratio (eoy) | x | 34.6 | 21.7 | 159.4% | |
Price / Book Value ratio | x | 4.1 | 6.2 | 65.5% | |
Dividend payout | % | 0 | 14.3 | -0.0% | |
Avg Mkt Cap | Rs m | 518 | 65,717 | 0.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 56 | 1,441 | 3.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 145 | 11,736 | 1.2% | |
Other income | Rs m | 3 | 309 | 1.0% | |
Total revenues | Rs m | 148 | 12,044 | 1.2% | |
Gross profit | Rs m | 16 | 3,996 | 0.4% | |
Depreciation | Rs m | 16 | 903 | 1.8% | |
Interest | Rs m | 4 | 584 | 0.7% | |
Profit before tax | Rs m | -1 | 2,818 | -0.0% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 694 | 0.0% | |
Profit after tax | Rs m | -1 | 2,124 | -0.0% | |
Gross profit margin | % | 11.0 | 34.0 | 32.4% | |
Effective tax rate | % | 0 | 24.6 | -0.0% | |
Net profit margin | % | -0.6 | 18.1 | -3.4% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 59 | 4,836 | 1.2% | |
Current liabilities | Rs m | 16 | 1,444 | 1.1% | |
Net working cap to sales | % | 29.5 | 28.9 | 102.2% | |
Current ratio | x | 3.7 | 3.3 | 110.3% | |
Inventory Days | Days | 88 | 115 | 76.1% | |
Debtors Days | Days | 590 | 18 | 3,254.0% | |
Net fixed assets | Rs m | 115 | 12,667 | 0.9% | |
Share capital | Rs m | 103 | 1,015 | 10.1% | |
"Free" reserves | Rs m | 25 | 9,584 | 0.3% | |
Net worth | Rs m | 128 | 10,599 | 1.2% | |
Long term debt | Rs m | 10 | 0 | - | |
Total assets | Rs m | 173 | 17,503 | 1.0% | |
Interest coverage | x | 0.8 | 5.8 | 13.5% | |
Debt to equity ratio | x | 0.1 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.7 | 124.3% | |
Return on assets | % | 1.9 | 15.5 | 12.2% | |
Return on equity | % | -0.7 | 20.0 | -3.5% | |
Return on capital | % | 2.4 | 32.1 | 7.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 2 | 0.0% | |
Fx outflow | Rs m | 0 | 55 | 0.0% | |
Net fx | Rs m | 0 | -53 | -0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 0 | 3,272 | -0.0% | |
From Investments | Rs m | 2 | -4,652 | -0.0% | |
From Financial Activity | Rs m | -9 | 1,434 | -0.7% | |
Net Cashflow | Rs m | -8 | 54 | -14.5% |
Indian Promoters | % | 18.7 | 49.8 | 37.6% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 38.8 | - | |
FIIs | % | 0.0 | 24.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 81.3 | 50.2 | 162.0% | |
Shareholders | 1,512 | 77,152 | 2.0% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare ASPIRA PATHLAB & DIAGNOSTICS With: APOLLO HOSPITALS DR. LAL PATHLABS METROPOLIS HEALTHCARE KIMS NARAYANA HRUDAYALAYA
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | ASPIRA PATHLAB & DIAGNOSTICS | RAINBOW CHILDRENS MEDICARE | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | 4.98% | -0.42% | -0.08% |
1-Month | -1.20% | 2.62% | 0.53% |
1-Year | -11.42% | 56.26% | 50.88% |
3-Year CAGR | -1.76% | 44.38% | 13.33% |
5-Year CAGR | -4.03% | 24.65% | 21.12% |
* Compound Annual Growth Rate
Here are more details on the ASPIRA PATHLAB & DIAGNOSTICS share price and the RAINBOW CHILDRENS MEDICARE share price.
Moving on to shareholding structures...
The promoters of ASPIRA PATHLAB & DIAGNOSTICS hold a 18.7% stake in the company. In case of RAINBOW CHILDRENS MEDICARE the stake stands at 49.8%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASPIRA PATHLAB & DIAGNOSTICS and the shareholding pattern of RAINBOW CHILDRENS MEDICARE.
Finally, a word on dividends...
In the most recent financial year, ASPIRA PATHLAB & DIAGNOSTICS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.
RAINBOW CHILDRENS MEDICARE paid Rs 3.0, and its dividend payout ratio stood at 14.3%.
You may visit here to review the dividend history of ASPIRA PATHLAB & DIAGNOSTICS , and the dividend history of RAINBOW CHILDRENS MEDICARE.
For a sector overview, read our pharmaceuticals sector report.
Indian share markets continued the momentum as the session progressed and ended the day higher.